Compare CNXN & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNXN | QDEL |
|---|---|---|
| Founded | 1982 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 1998 | N/A |
| Metric | CNXN | QDEL |
|---|---|---|
| Price | $58.16 | $26.76 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $40.00 |
| AVG Volume (30 Days) | 63.5K | ★ 1.0M |
| Earning Date | 02-04-2026 | 02-11-2026 |
| Dividend Yield | ★ 1.04% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.24 | N/A |
| Revenue | ★ $2,878,704,000.00 | $2,714,400,000.00 |
| Revenue This Year | $5.74 | N/A |
| Revenue Next Year | $4.56 | $2.28 |
| P/E Ratio | $17.87 | ★ N/A |
| Revenue Growth | ★ 3.19 | N/A |
| 52 Week Low | $54.97 | $19.50 |
| 52 Week High | $74.84 | $46.11 |
| Indicator | CNXN | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 37.67 |
| Support Level | $56.20 | $27.19 |
| Resistance Level | $58.44 | $35.58 |
| Average True Range (ATR) | 1.32 | 2.03 |
| MACD | -0.02 | -0.88 |
| Stochastic Oscillator | 61.78 | 9.93 |
PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.